MI Bioresearch Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:MI Bioresearch Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10817
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥100,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
MI Bioresearch Inc (MI), formerly Molecular Imaging Inc, is a research institute that offers pharmacology research services. The institute offers services such as oncology pharmacology, immuno oncology, in vitro services, imaging and radiation. Its oncology pharmacology include subcutaneous models, orthotopic models, metastasis models, disseminated models and PDX models. MI also offers services such as validation, candidate selection, optimization, modeling, PK and PD profiling, biodistribution, custom models, consulting, and ex-vivo. The institute serves pharmaceutical, diagnostics, and medical device sectors. Molecular Imaging is headquartered in Ann Arbor, Michigan, the US.

MI Bioresearch Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
MI Bioresearch Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
MI Bioresearch Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
MI Bioresearch Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
MI Bioresearch Inc, Medical Devices Deals, 2012 to YTD 2018 8
MI Bioresearch Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
MI Bioresearch Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Molecular Imaging Raises USD1.5 Million in Venture Financing 10
Molecular Imaging Raises US$3.5 Million In Venture Financing 11
Molecular Imaging Research Raises Additional US$2.85 Million In Series A Financing 12
MI Bioresearch Inc – Key Competitors 13
MI Bioresearch Inc – Key Employees 14
MI Bioresearch Inc – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
MI Bioresearch Inc, Pharmaceuticals & Healthcare, Key Facts 2
MI Bioresearch Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 2
MI Bioresearch Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
MI Bioresearch Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
MI Bioresearch Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
MI Bioresearch Inc, Medical Devices Deals, 2012 to YTD 2018 8
MI Bioresearch Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Molecular Imaging Raises USD1.5 Million in Venture Financing 10
Molecular Imaging Raises US$3.5 Million In Venture Financing 11
Molecular Imaging Research Raises Additional US$2.85 Million In Series A Financing 12
MI Bioresearch Inc, Key Competitors 13
MI Bioresearch Inc, Key Employees 14

List of Figures
MI Bioresearch Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
MI Bioresearch Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
MI Bioresearch Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
MI Bioresearch Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
MI Bioresearch Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
MI Bioresearch Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
MI Bioresearch Inc, Medical Devices Deals, 2012 to YTD 2018 8

★海外企業調査レポート[MI Bioresearch Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Brembo SpA:企業の戦略・SWOT・財務情報
    Brembo SpA - Strategy, SWOT and Corporate Finance Report Summary Brembo SpA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Natsionalna Elektricheska Kompania EAD:企業の戦略的SWOT分析
    Natsionalna Elektricheska Kompania EAD - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and ma …
  • PricewaterhouseCoopers LLP (UK):企業の戦略的SWOT分析
    PricewaterhouseCoopers LLP (UK) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • AmSurg Corp (EVHC):製薬・医療:M&Aディール及び事業提携情報
    Summary AmSurg Corp (AmSurg) is a healthcare service provider that develops, acquires and operates surgery centers. The company is a surgery center management and development company that manages hospitals and health systems. It provides strategic and operational management of surgery centers that i …
  • National Australia Bank Private Wealth:企業の戦略・SWOT・財務情報
    National Australia Bank Private Wealth - Strategy, SWOT and Corporate Finance Report Summary National Australia Bank Private Wealth - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Baker Hughes, a GE Co LLC (BHGE):企業の財務・戦略的SWOT分析
    Baker Hughes, a GE Co LLC (BHGE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Camurus AB (CAMX):企業の財務・戦略的SWOT分析
    Summary Camurus AB (Camurus), a subsidiary of Sandberg Development AB, is a pharmaceutical company that carries out development and commercialization of treatments for the patients suffering from chronic diseases. The company’s technology includes smart and versatile drug delivery, injection depot, …
  • Xiwang Special Steel Company Limited:企業の戦略・SWOT・財務情報
    Xiwang Special Steel Company Limited - Strategy, SWOT and Corporate Finance Report Summary Xiwang Special Steel Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • China Mengniu Dairy Co Ltd:企業の戦略・SWOT・財務情報
    China Mengniu Dairy Co Ltd - Strategy, SWOT and Corporate Finance Report Summary China Mengniu Dairy Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Orpea SA (ORP):製薬・医療:M&Aディール及び事業提携情報
    Summary Orpea SA (Orpea) is a healthcare consulting company that offers clinical care services. The company provides services such as suite care clinic services, retirement homes, and mental hospital services, among others. Its mental hospital services include treatment of mood disorders, overuse sy …
  • AIB Group (UK) plc:企業の戦略的SWOT分析
    AIB Group (UK) plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Chesapeake Energy Corp (CHK):石油・ガス:M&Aディール及び事業提携情報
    Summary Chesapeake Energy Corp (Chesapeake) is an upstream oil and gas company in the US. The company explores for, develops and produces oil and gas from its assets. It has liquid operations in Eagle Ford Shale; the Utica Shale; the Granite Wash, Cleveland, Tonkawa and Mississippian Lime plays in t …
  • Buzzi Unicem SpA:戦略・SWOT・企業財務分析
    Buzzi Unicem SpA - Strategy, SWOT and Corporate Finance Report Summary Buzzi Unicem SpA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Casino Guichard-Perrachon SA:戦略・SWOT・企業財務分析
    Casino Guichard-Perrachon SA - Strategy, SWOT and Corporate Finance Report Summary Casino Guichard-Perrachon SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Foundation for Innovative New Diagnostics-医療機器分野:企業M&A・提携分析
    Summary Foundation for Innovative New Diagnostics (FIND) is a non-profit organization that offers diagnostic tests. The organization develops and implements new diagnostic technologies for the development of diagnostic tests. Its services include diagnostic technologies development, quality-assured …
  • Diffusion Pharmaceuticals Inc (DFFN):製薬・医療:M&Aディール及び事業提携情報
    Summary Diffusion Pharmaceuticals Inc (Diffusion), formerly Diffusion Pharmaceuticals LLC is a clinical stage biotechnology company that develops standard of care therapies. The company improves cancer treatments such as radiation therapy and chemotherapy in treatment-resistant solid tumors, includi …
  • Glanbia Nutritionals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Glanbia Nutritionals Inc (Glanbia Nutritionals), a subsidiary of Glanbia plc is a provider of nutritional ingredients, functional ingredients, and customized premix solutions. The company manufactures and markets customized micronutrient blends, vitamins, minerals, amino acids, colors and sp …
  • National Bank Of Bahrain Bsc:企業の戦略・SWOT・財務分析
    National Bank Of Bahrain Bsc - Strategy, SWOT and Corporate Finance Report Summary National Bank Of Bahrain Bsc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • MMC Norilsk Nickel:企業のM&A・事業提携・投資動向
    MMC Norilsk Nickel - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's MMC Norilsk Nickel Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • Tektronix, Inc.:企業の戦略的SWOT分析
    Tektronix, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆